Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Archives for biotech

Webcast: In Vitro Diagnostics – Upcoming Regulatory Developments in the U.S. and European Union: Are You Ready for the Transition?

Did you miss our recent webcast “In Vitro Diagnostics – Upcoming Regulatory Developments in the US and EU: Are You Ready for the Transition?” You can listen and watch it here.

A Glimpse into the Vital Core of Tumor Cell Development

By John Leavitt, Ph.D. Nerac Analyst
Originally Published: August 12, 2014
In 1987, my colleagues at Stanford and I published a paper that clearly demonstrated that expression of a charge-altered mutant human beta-actin (glycine to aspartic acid substitution at amino acid 245; G245D) caused non-tumorigenic, immortalized human fibroblasts to form aggressive tumors in nude mice (Leavitt et al, 1987a). Read more

New Diagnostics in Medicine – Cheap, Fast, and Accurate

By Stephen Buxser, Ph.D.
Originally Published: July 15, 2014
A major, if not the major, driver of advances in medicine is the development of better diagnostics. Read more

The Holy Grail of Cancer Research – A Protein That Enables Aggressive Tumor Growth and Metastasis

By John Leavitt, Ph.D. Nerac Analyst
Originally Published July 21, 2014
Such a protein appears to be described in a paper published in the journal Molecular Cancer Therapeutics in February 2014 by Heinz-Josef Lenz at the Keck School of Medicine of the University of Southern California in collaboration with colleagues at the University of Graz in Austria. Read more

Nucleic and Amino Acid Sequence Research in an Intellectual Property Management Strategy

The global market for biotechnology represents a large and complex amalgamation of different products that touches many different industry segments. In the healthcare industry alone, biologics represent a greater than $125 billion global market, and biosimilars legislation in the US and EU has spawned new generic biologics markets that will continue to grow. In addition, the even larger and more rapidly growing market for personalized medicine is driving biotechnology-based diagnostic and health management tools. In the agricultural industries, the market for genetically modified seeds and crops that are pest and disease resistant continues to grow. In the energy industries, large rounds of funding continue to drive the development of biofuels, the quality and production of which is likely to be improved by biotechnological advances. Participants in all of these markets rely on positive innovations and intellectual property (IP) rights to maintain and grow their market shares.Read more

  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.